Barzilai University Medical Center

Ashkelon 7830604

0 studies enrolling now · 5 studies all time

What they study most

Hereditary Angioedema, Hereditary Angioedema (HAE), Pulmonary Arterial Hypertension

Studies at this site

• Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks — Completed
• CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema — Completed
• CSL312 (Garadacimab) in the Prevention of Hereditary Angioedema Attacks — Completed
• Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH — Stopped early
• A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE) — Completed